Analysts await Arotech Corporation (NASDAQ:ARTX) to report earnings on Mar, 14 for the fiscal quarter ending Dec 2015.

They expect $-0.01 EPS, down 200% or $0.02 from last year’s $0.01 per share.

At the moment 1 analyst is watching Arotech Corporation (NASDAQ:ARTX), 0 rate it “Buy”, 1 “Outperform”, 0 “Underperform”, 0 “Sell”, while 0 “Hold”.

Looking forward, for the quarter ending Mar-16, 1 analyst has a mean sales target of 27.95 million. For the quarter ending Jun-16, 1 analyst has a mean sales target of 28.75 million whilst for the year ending Dec-16, 1 analyst has a mean target of 114.90 million.

In terms of earnings per share, 1 analyst has a 0.04 EPS mean target for the quarter ending Mar-16, for the quarter ending Jun-16, 1 analyst has a 0.05 EPS mean target and for the quarter ending Jun-16 there are 1 estimate of 0.12 EPS.

Total shares held by institutions as of the most recent company filings are 2,986,034 with a reported 356,738 bought and 73,905 sold. These holdings make up 12.99% of the company’s outstanding shares.

The stock decreased 1.17% or $0.03 during the last trading session, hitting $3.60. Arotech Corporation (NASDAQ:ARTX) has risen 60.83% over the past 6 months and is uptrending.